GEN Exclusives

More »

GEN News Highlights

More »
Jul 22, 2009

Polish University to Use Cellectricon’s Transfection System

  • The University of Lodz, Poland, will invest in Cellectricon’s Cellaxess®HT. The university plans to use the product for its research program focusing on cell biology and molecular genetics of clinically relevant genes related to cancer treatment.

    Cellaxess®HT is a fully automated workstation for high-throughput transfection. The system enables reagent-free delivery of siRNA and cDNA to a range of primary cells and cell lines.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?